Cargando…
The efficacy and safety of Clostridium butyricum and Bacillus coagulans in Helicobacter pylori eradication treatment: An open-label, single-arm pilot study
BACKGROUND: Helicobacter pylori (H pylori) infection plays a critical role in gastritis-associated diseases, gastroduodenal ulcers, and even gastric cancer. Studies have shown that probiotics may exhibit antagonistic activity against H pylori. METHODS: This study aimed to assess the efficacy and saf...
Autores principales: | Zhang, Jian, Guo, Jingzhi, Li, Dan, Chen, Min, Liu, Jie, Feng, Chenchen, He, Qi, Zhao, Jing, Zhang, Luyao, Chen, Jie, Shi, Yongquan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7647598/ https://www.ncbi.nlm.nih.gov/pubmed/33157939 http://dx.doi.org/10.1097/MD.0000000000022976 |
Ejemplares similares
-
Optimization of an economical medium composition for the coculture of Clostridium butyricum and Bacillus coagulans
por: Li, Yonghong, et al.
Publicado: (2022) -
Berberine containing quadruple therapy for initial Helicobacter pylori eradication: An open-label randomized phase IV trial
por: Zhang, Di, et al.
Publicado: (2017) -
The efficacy and safety of different bismuth agents in Helicobacter pylori first-line eradication: A multicenter, randomized, controlled clinical trial
por: Cao, Yaping, et al.
Publicado: (2021) -
The influence of pretreatment with PPI on Helicobacter pylori eradication: A systematic review and meta-analysis
por: Kuang, Sheng, et al.
Publicado: (2021) -
Bacillus coagulans (PROBACI) in treating constipation-dominant functional bowel disorders
por: Chang, Chen-Wang, et al.
Publicado: (2020)